Should You Add Mesoblast limited (MESO) Stock to Your Portfolio?
Monday, April 13, 2020 11:56 AM | InvestorsObserver Analysts
Mesoblast limited (MESO) stock is higher by 14.98% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives MESO stock a score of 87 out of a possible 100.That rank is primarily influenced by a short-term technical score of 96. MESO's rank also includes a long-term technical score of 83. The fundamental score for MESO is 83. In addition to the average rating from Wall Street analysts, MESO stock has a mean target price of 13.8. This means analysts expect the stock to increase 109.09% over the next 12 months.
https://www.investorsobserver.com/news/stock-update/should-you-add-mesoblast-limited-meso-stock-to-your-portfolio
Cell Therapy News/Articles, page-1649
-
- There are more pages in this discussion • 16,210 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.5¢ |
Change
0.040(4.52%) |
Mkt cap ! $1.061B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $2.734M | 2.981M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 27652 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 28365 | 12 |
View Market Depth
| Last trade - 11.55am 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |